Table:
begin	end	state
1	21	cytoplasmic
22	44	transmembrane
45	55	non-cytoplasmic
56	76	transmembrane
77	87	cytoplasmic
88	106	transmembrane
107	113	non-cytoplasmic
114	134	transmembrane
135	145	cytoplasmic
146	170	transmembrane
171	176	non-cytoplasmic
177	202	transmembrane
203	254	cytoplasmic
255	275	transmembrane
276	286	non-cytoplasmic
287	310	transmembrane
311	317	cytoplasmic
318	336	transmembrane
337	341	non-cytoplasmic
342	365	transmembrane
366	383	cytoplasmic
384	404	transmembrane
405	409	non-cytoplasmic
410	431	transmembrane
432	447	cytoplasmic

Input:
>AO353_14270
MRTIDVHEVIDNARFNRFHWRVLCWCALIIIFDGYDLVIYGVVLPMLMKDWGLSPLQAGA
LGSYALFGMMFGALFFGPLSDRIGRKKAITLCVMLFSGFTVLNGFAGNPTEFGICRFIAG
LGIGGVMPNVVALMNEYAPKKIRSTLVAIMFSGYSVGGMLSAGLGIVLIPSFGWQSVFYV
AIVPLLLLPLIMCFLPESVGFMLRQGRNEQARKVLQRVDPAYVAQATDQLHMTEVKGSGT
PVLQLFREGRAMRTLMLWLAFFCCLLTVYALSSWLPKLMANAGYSLGSSLSFLLVLNFGA
IFGAVGGGVLGDKLNLPRVLAVFFSIAAVSITLLGFNSPTPVLYLLIAIAGATTIGSQIL
LYACAAQFYSMAIRSTGLGWASGIGRNGAIVGPLLGGALLGISLPLQLNFMAFALPGAIA
AIAMAVFAISCQRSSKGVASRLVPTSV

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server